血友病研究暨防治中心經營模式探討 產學協同開發策略運用 - 政大學術集成
68
0
0
全文
(2) ㈻㊫學. •‧ 國. 立立. 政 治 大 –. •‧. n. er. io. sit. y. Nat. al. Ch. engchi. i n U. v. “. “. “. ” i.
(3) “. ”. 立立. 政 治 大. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. Ch. engchi. ii. i n U. v.
(4) Hemophilia Treatment Center, HTC HTC. 政 治 大 HTC. 立立. 2005 15. •‧. •‧ 國. ㈻㊫學 y. io. n. al. sit. SWOT. er. Nat. Porter. Ch. engchi. i n U. v.
(5) Abstract Hemophilia is an inherited bleeding disorder that causes the blood may not clot properly, most affected boys. Managing with bleeding issue within short time that could be a risk to patients. Those patients, choose a professional comprehensive treatment center (Hemophilia Treatment Center, HTC) usually refer the patient group advises or review the proposal submitted by the HTC’s professional medical service either. Most of them to be concerned bleeding issue, viral infection, arthroplasty and rehabilitation programs, besides eliminate. 治 政 the psychological barriers, convenience for medical 大service provided and 立立 conduct the education programs sharing to families. Bureau of National •‧ 國. ㈻㊫學. Insurance allocated the independent budget for rare disease, AIDS and. •‧. Hemophilia since 2005, about 15% increase annually. To these incentives, some hospitals start to run HTC business recently providing medical service to patient. y. Nat. io. sit. with Hemophilia. The study is aiming HCRC, that is a collaborative. n. al. er. development project by both industry and medical center, which locates in north. Ch. i n U. v. of Taiwan. With Porter’s five force analysis and value chain instrument and. engchi. SWOT analysis, to validate the key success factors for business model and environment conquer strategy, respectively. That result may offer the new strategy to HCRC for further business development.. iv.
(6) ................................................................................................................................. I ABSTRACT ................................................................................................................. IV ......................................................................................................................... VII ....................................................................................................................... VIII .................................................................................................................. 1 ............................................................................................ 1. 政 治 大 .................................................................. 5. ............................................................................................ 3. 立立 •‧ 國. ㈻㊫學. ............................................................................................ 5 .................................................................................... 7. •‧. (WORLD FEDERATION OF HEMOPHILIA) ............................ 9. .......................................................................................... 11. n. al. er. io. sit. y. Nat. .............................................................................. 10. Ch. i n U. v. ......................................................................... 15. e n.......................................................................... 15 gchi .......................................................................... 18 .................................................................................. 21. ....................................................................................................... 25 ...................................................................................................... 25 ...................................................................... 26 .................................................................................. 29 .................................................................................. 32 v.
(7) .............................................................................................. 33 ...................................................................................... 37 .............................................................................. 37 HCRC. 2003 – 2009. ............................................................ 41. ...................................................................................... 45 ...................................................................................... 46 ................................................................................................... 50 .............................................................................................................. 50. 政 治 大. .............................................................................................................. 53. 立立. ....................................................................................................................... 55. •‧ 國. ㈻㊫學. ............................................................................................................................... •‧. n. er. io. sit. y. Nat. al. Ch. engchi. vi. i n U. v.
(8) 2.1. ................................................ 6. 3.1 2003 .................................... 18 5.1. ,. ,. ........................................................................................................ 41. 立立. 政 治 大. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. Ch. engchi. vii. i n U. v.
(9) 1.1. ........................................................................................................................ 4. 2.1. .................................................... 7. 2.2. ........................................................................................................ 8. 3.1. 2005. 4.1 HCRC. .................................................................................... 16. ........................................................................................................... 27. 4.2. .......................................... 28. 4.3. .................................................................................. 29. 4.4. •‧ 國. HCRC. ............................................. 35. y. sit. .................................................................................. 37 ....................................................................... 38. n. al. –. er. io. 5.2. .................................................................................................................. 33. Nat. 5.1. .............................................................................................................. 33. •‧. 4.8. ............................................................................................... 31. ㈻㊫學. 4.7. .......................................................... 31. 立立. 4.5 HCRC 4.6. 政 治 大. 5.3 5.4 5.5 SNQ. Ch. i n U. v. ...................................................................................................... 39. engchi. ...................................................................................................... 40 ................................................................................................. 42. viii.
(10) 政 治 大. 立立. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. Ch. engchi. i n U. C. v. B. 1980 (HIV) HIV 90%, 40%. 50%. 53 1.
(11) 立立. 政 治 大. •‧ 國. ㈻㊫學. 1975. •‧. n. er. io. sit. y. Nat. al. C1983 hengchi. i n U. v. (Integrated Care). 2012. 127.7. 2.
(12) 立立. 政 治 大 2003. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. Ch. engchi. i n U. v. SWOT. 1. 2. 3.. 3.
(13) 1.1 1. 2. 3. SWOT. 1.1. 1.1. 立立. 政 治 大. ㈻㊫學 •‧. •‧ 國 io. sit. y. Nat. n. al. er. 4.. Ch. engchi. 4. i n U. v.
(14) X A. 立立. B. 政 治 大. Ch. engchi U. 40 2/3. y 10 1. n. al. sit. 102. er. io. 1,300. A. Nat. B. •‧. •‧ 國. A. B. ㈻㊫學. A. 10. v ni 2. 1/3. 2.1. 1. http://www.nhi.gov.tw/resource/Webdata/15049_1_10210. 2. http://hemophiliacs.pixnet.net/blog/post/88154745. .xls.
(15) 2.1. 3. 50-150%. 立立 •‧ 國. 1%. •‧. n. al. er. io. sit. y. Nat. 2.. 3.. 3. 2.1. ㈻㊫學. 1.. 政 治 大. Ch. e1-5n%g c h i 5-40%. http://www.wfh.org/en/page.aspx?pid=643 6. i n U. v.
(16) 2.1. 立立. 政 治 大. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. •. Ch. engchi U. •. v ni. von Willebrand. •. •. 7. (. 2.2).
(17) 2.2. 立立. on demand. •‧ 國. ㈻㊫學. prophylaxis therapy. •‧ y. Nat. n. al. C. er. io. B. Kogenate FS Advate. sit. therapy. 政 治 大. Ch. e n gA c h i. ReFacto. i n U. v. Xyntha. 95% 4. 5% (vWD)5. DDAVP Desmopressin. 4. 8. 6. B.
(18) 7 8. BeneFIX. NovoSeven. 立立. Feiba. 政 治 大. C. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. (World Federation of Hemophilia). Ch. engchi. 7. 9. i n U. v.
(19) 1963. 50 122 Mr. Frank. Schnabel. 1989. 4. 17. “. ”. 政 治 大 (National Hemophilia Foundation, NHF) 立立. 1948. •‧. •‧ 國. ㈻㊫學. .. ,. y. .. al. n. and Scientific Advisory Council , MASAC). Ch. engchi. (Medical. er. io. sit. Nat. (CDC). i n U. v. 9. 1973. Hemophilia. Treatment Center, HTC. 9. http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=1&contentid=476&r ptname= 10.
(20) 10. 1975. of the Public Health Service Art. section 1131. 22 HTC 141. NHF Consortium, EHC). HTC. (European Haemophilia 2008. 立立. 政 治 大. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. C90h. engchi. i n U. v. 1995 2.3. 10. http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=249&contentid=385 11.
(21) 2.3. 立立. 政 治 大. •‧. •‧ 國. ㈻㊫學 2004. y. Nat. n. al. er. io. WHO. sit. 12. Ch. engchi. 12. i n U. v.
(22) 1983. 立立. 政 治 大. 80. y. Nat. n. al. sit. ,. er. io 13. •‧. •‧ 國. ㈻㊫學. 11. Ch. ,. engchi. v i n U1995. 1998. 12. ,. , ,. / (. , ,. 11. http://zh.wikipedia.org/wiki/. 12. http://www.hemophilia.org.tw. 13. http://hemophiliaformosa.blogspot.tw 13. ) /.
(23) , NHF. ,. , 2003 HTC Hemophilia Care & Research Center, HCRC. HCRC. ,. ,. 立立. , 政 治 大 2006. ,. 15. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. Ch. engchi. 14. i n U. v.
(24) (WHO 1943) 1950 1961. 立立. 1988. 政 治 大. •‧ 國. ㈻㊫學. 1995 -. •‧. n. 210. er. io. sit. y. Nat. al. 1999. Ch. i n U. engchi. 2002. (. , , 15. v. 3.1). 1998.
(25) 2004. 45:55 “. ” 2004. 立立. 政 治 大. y. •‧. •‧ 國. ㈻㊫學 sit. io. n. al. 2005. er. Nat. 3.1. Ch. engchi. 16. i n U. v.
(26) , ;. ; ,. 2002 ;. 2005. GDP. 3.1) 政 治 大. (. 立立. •‧. •‧ 國. ㈻㊫學. n. al. er. io. sit. y. Nat. DRG. Ch. engchi. 17. i n U. v.
(27) 3.1 2003. 政 治 大. 立立. sit. (OECD) (2005/11/17). er. io. :. ,. y. •‧. •‧ 國. ㈻㊫學. Nat. : 2003. n. al. Ch. engchi. i n U. v. 2000 , 2004. ,. 90 ,. ( secondary prophylaxis treatment). ,. ,. 12 18.
(28) ( primary prophylaxis treatment) ‧ , (. 1997 2007. ,. 3.2). 3.2. 政 治 大. 立立. •‧. •‧ 國. ㈻㊫學 er. io. sit. y. Nat. al. n. 2004. Ch. , (. engchi. , i n U. v. 15%. 0.3%). ,. , 32. ‧. (. 2004. ,. 2.6 (. 127.7 24.0. 2012. ,. ). 2012. ). ,. , 29.2. 5.5. ;. 19. ,.
(29) 20,930. ,. ,. 14. 149. , ,. ,. , 1997 per capita 1997. 2007. 2.28 IU per capita,. 0.23 IU per capita. 3.2). 2007. 0.46 IU per capita (. 15. (2005. ). 32. 立立. ). •‧. •‧ 國. ㈻㊫學 y. Nat. Yonsei Med J. 2013 Jan;54(1):71-80.. n. al. er. io. sit. iu per capita;. Ch. i n U. engchi. v. ,. :. , ,. 15. (2012. 政 治 大. 3.2. ,. 0.96 IU. , 2011. , ,. 14. : http://www.24drs.com/Daily/article.asp?x_no=8610&page=1. 15. : http://www.coa.gov.tw/view.php?catid=9917 20.
(30) 16. , 2,500 3. (FDA). 30. (. 3. 0.5-2),. 治 drug) 政 orphan 大 ,. (. 立立. ,. •‧ 國. ,. ㈻㊫學. ,. ,. •‧ y. Nat. 2005. ,. er. io. 15%. ,. 17. ,. ,. ,. sit. 2. 25%. n. al. C h,. engchi. i n U. v. ,. , , Porter (1980). ,. ,. ,. 16. http://www.moneydj.com/kmdj/wiki/WikiViewer.aspx?KeyID=c0605645-88eb-4ad4-a2f0-9a1e8cb96d b6&Versi on=20#ixzz2oEIy6GQH 17. http://www.ibmi.org.tw/client/NewsDetail.php?DSCDOCID=0m96o9cx7xynbf1c 21.
(31) ,. (. ). ,. , ,. ,. ,. Porter. (. 3.3):. 3.3. 立立. 政 治 大. •‧. •‧ 國. ㈻㊫學 er. io. sit. y. Nat. n. al. Ch. engchi. i n U. v. 1 HCRC. :. , ,. , ,. ,. ,. ,. HCRC. , 22.
(32) :. 2 (Gene therapy) , , ,. , ,. 3. ,. ,. ㈻㊫學. •‧ 國. 立立. 政 治 大. , ,. •‧. /. (. n. al. er. io. sit. y. Nat. 4. ). ,. Ch. engchi. i n U. v. ,. ,. , (. ,. ),. ,. ,. ,. ,. 5 , 23.
(33) ,. ,. , , ,. : ,. ;. ,. 立立. ,. 政 治 大 , ,. •‧ 國. ㈻㊫學. ,. y er. io. iv. n. al. ,. sit. ,. n, Ch , U engchi ,. ,. ,. •‧. , HTC. :. ,. Nat. ,. ;. ,. 24. ,. , HTC.
(34) HCRC. !. 2000. , ,. ,. 政 治 大 ,. ,. ;. ,. HCRC. y. sit. io. ,. ,. n. al. er. Nat. ,. ,. ,. SARS. ,. •‧. ,. ,. ㈻㊫學. ,. •‧ 國. 立立. Ch. ,. engchi. i n U. v. HCRC. ,. : ,. ,. :. Tri-Service General Hospital 1946. 2000 1,850. 25.
(35) (Baxter International Inc.). Dr. Don Baxter. 1931. (Deerfield). (Renal) (Medication Delivery). 立立. (BioScience). 政 治 大. •‧. •‧ 國. ㈻㊫學 y. Nat. n. al. er. io. sit. 2003. Ch. Care & Research Center, HCRC). n U engchi. iv. (Hemophilia. HCRC. 18. 2003. 18. Baxter 2005 annual report 26. 9.
(36) 17. HCRC – TSGH 4.1 4.1 HCRC. 立立. 政 治 大. ㈻㊫學 •‧. •‧ 國. y. Nat. io. (. n. al. sit. ,. Ch. engchi. 27. er. / BAXTER. 4.2). i n U. v.
(37) 4.2. 政 治 大. 立立 •‧ 國. ㈻㊫學 , ,. y. Nat. io. sit. ,. n. al. er. •. •. ,. •‧. •. Ch. •. (Advoy),. engchi. i n U. v. ,. , •. , ,. • •. , ,. 28.
(38) 政 治 大. 立立. •‧. •‧ 國. ㈻㊫學 y. n. al. er. io 4.3. sit. Nat. 4.3. Ch. engchi. 29. i n U. v.
(39) 政 治 大. 立立. •‧. •‧ 國. ㈻㊫學. 1991. sit. v ni. (. n. al. er. io 1.. (the Bayh-Dole Act). y. ─. Nat. 1980. Ch. e n g c)h 3.i U /. ) 2. (. )19. 4.4. 19. http://www.iaci.nkfust.edu.tw/2006Industry-EducationHandbook/index.html). 30. (.
(40) 4.4. 政 治 大 HCRC. •‧. 4.5. n. al. er. io. sit. y. ;. Nat. ,. ㈻㊫學. •‧ 國. 立立. Ch. engchi. 4.5 HCRC. 31. i n U. v.
(41) HCRC. Start. ups. 政 治 大 HCRC. ㈻㊫學. •‧ 國. 立立 Drucker ( 1954). •‧. Ansoff. Nat. sit. y. (1965). n. al. er. io. Brunner (2001). Ch. engchi. 4.6. 32. i n U. v. – HCRC.
(42) 4.6. 立立. 政 治 大. •‧. •‧ 國. ㈻㊫學. n. al. er. io. sit. y. Nat. 4.7. Ch. engchi. 33. i n U. v.
(43) HCRC. Kolter (1967) Keller (2001). ,. 15. HCRC. (product differentiation). , (branding). ,. (market segmentation) ,. ,. ,. n. al. sit. ,. er. io. 09. ,. y. Nat. KPI,. ,. (market. •‧. research). ,. ㈻㊫學. •‧ 國. 立立. 政 治 大 , (target customers). Ch. 17. n U engchi. iv. , HCRC. 2003. ,. : :. (. :2003 – 2004) 5.1. , ,. , ,. , , 34. ,.
(44) ,. ,. , ( ). ,. ,. ,. ,. ,. 立立. 4.8. ,. 政 治 大. HCRC. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. Ch. engchi. i n U. v. 4.8. :. (. :2004 - ) 35.
(45) RT-PCR LA Children Hospital. :. (2006- ). 立立. 政 治 大 HCRC. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. Ch. engchi. ,. i n U. v. ,. ,. 36.
(46) Porter (1985). (value Chain). , HCRC. , ( 立立. ,. ,. 政 治 大 5.1). •‧ 國. ,. •‧. HCRC. sit. y. Nat. io. 5.1. n. al. er. ;. ;. ㈻㊫學. ,. Ch. engchi. , 37. i n U. v.
(47) (. 5.2),. , ,. ,. ,. , , ,. HCRC. 5.2. –. 立立. 政 治 大. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al (. Ch. engchi. i n U. v. 5.3),. /. ,. ,. ,. ,. ,. ,. , ,. ,. ,. , ,. , 38. ,.
(48) ,. ,. ,. ,. ,. 5.3. 立立. 政 治 大. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. Ch. engchi. i n U. v. (. 39. 5.4).
(49) 5.4. 政 治 大. 立立. •‧. •‧ 國. ㈻㊫學 HCRC. y. Nat. ,. n. ,. Ch. HCRC. , ;. engchi. er. io. al. ;. sit. ,. i ,U n. v. ,. ;. ,. LA Children Hospital. ,. HTC. , ;. ,. , ,. HCRC. ,. , ;. 40. ,.
(50) HCRC. 2003 – 2009. HCRC. 0. 0. 145. 9. 9.4. n. al. SNQ. er. io. /. 5.1 ,. y. HCRC. sit. HCRC. Nat. ,2010. 5.1. •‧. 42.7. 政 治 大 LA Children Hospital. ㈻㊫學. •‧ 國. 立立. 20. Ch. e n, g c h i. i n U. v. 20. http://wwwu.tsgh.ndmctsgh.edu.tw/hem/hema_oncology/hemophilia_center/hemo_result.htm 41.
(51) 5.5 SNQ. HCRC. ,. ,. •‧. ,. ,. sit. n. al. er. io HCRC. y. Nat. :. ,. ㈻㊫學. •‧ 國. 立立. 政 治 大. Ch. i n U. engchi. v. ,. , ,. ,. ,. , ,. ,. ,. , ,. ,. , 42.
(52) ,. , ,. ,. ,. ‧ , 0. 145. ,. (. 1/3),. ,. ( ,. 政 治 大 ,. HCRC. 立立. ,. HCRC. ), HCRC. ㈻㊫學. •‧ 國. ,. ,. ,. •‧. , HCRC ,. ?. n. al. er. io. sit. y. Nat ?. ,. Ch. engchi. i n U. v. HCRC HCRC. ,. ,. : 1. , 43. ,.
(53) ,. , ,. 2. , ,. ,. ,. ,. 3. ,. 立立. ,. , 政 治 大. ,. ,. ,. n. al. er. io. sit. y. Nat. ,. ,. •‧. •‧ 國. ㈻㊫學. 4.. Ch. ,. i n U. ,. engchi. 15. v. ,. , ,. :. 1.. ,. ,. ,. , 2.. 3.. ,. ,. ,. , 44. ,.
(54) , 4.. (Switching Cost). 5. 6.. ,. ,. DRG. ,. , , , ‧. 立立. 政 治 大. , , ?. ㈻㊫學. •‧ 國. ,. ,. ,. ‧. •‧. HCRC. n. al. er. io. sit. y. Nat Rockart (1980). ,. Ch. engchi. ,. i n U. v. ,. , HCRC. 1. IMS. ,. ,. , ; 2.. ,. , (. ) 3.. ,. , ,. ; 4.. , 45. ; 5..
(55) , ,. Porter (1980). :. ,. HCRC. ,. SWOT. 立立. 政, 治 大 HCRC SWOT. ㈻㊫學. •‧ 國. HCRC. HCRC. 5.6 HCRC SWOT. •‧. n. er. io. sit. y. Nat. al. Ch. engchi. 46. i n U. v. (. 5.6).
(56) 5.7 HCRC SWOT. 政 治 大. 立立. io. , :. y ,. al. ,. n. ,. ,. Nat. HCRC. :. sit. :. ,. Ch. ;. engchi. i n U. v. ,. ;. ,. ,. ,. ;. ST. 5.7),. •‧. OS. (. er. HCRC. ,. •‧ 國. SWOT. ㈻㊫學. HCRC. ,. : HCRC. ,. 47.
(57) WO. : HCRC. ,. ,. ,. ,. , ,. ,. ; ,. ;. :. ,. ,. , ;. : 政 治 大 ,. ,. ,. 立立. :. SOP. ㈻㊫學. ,. ;. ,. HCRC. :. •‧. •‧ 國. ,. ;. ,. sit er. al. n. :. io. WT. y. Nat. , HCRC. C h HCRC engchi. i n U. v. ,. :. ,. ,. HCRC. ;. ,. ,. ,. ,. , , HCRC ,. , 48. ,.
(58) ,. ,. ,. , ,. ,. ,. , ,. ,. ,. ,. ,. 立立. 政 治 大. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. Ch. engchi. 49. i n U. v.
(59) ,. ,. ,. 立立 ,. ,. ,. ,. HTC. sit. n. al. er. io. ,. ,. •‧. ,. Nat ,. ,. y. ,. 政 治, 大. ㈻㊫學. ,. •‧ 國. ,. ,. C. Ch. engchi U ,. v ni. ( ). , , ,. 2005 15%. , ,. , ,. , 50.
(60) ,. HTC. ,. 15. ,. ,. , HTC. ,. , ,. ,. ,. 政 治 大 ,. 立立 ,. ,. ㈻㊫學. •‧ 國. ,. ,. •‧ sit. ,. al. n. ,. ,. er. io. ,. y. Nat. ;. ;. Ch. HCRC. engchi. HCRC. i n U. v. ,. ,. ,. ? HCRC ,. , ,. ,. ,. , ,. , ,. , 51.
(61) ,. , , ,. ,. ,. ,. ,. HCRC. ,. , ,. , ,. 政 治 大 ,. HCRC ,. , ,. ,. y. Nat. io. ,. n. al. HCRC. Ch. , HCRC –. engchi. sit. ,. er. ,. Fit-in. •‧. ; ,. ㈻㊫學. •‧ 國. 立立. , HCRC. i ,U n. v. / Baxter HCRC. ,. ,. ,. ,. ,. ? SWOT. HCRC. , ,. ,. ,. ; 52. ,.
(62) , , , ,. , ,. , , HCRC. ,. , , 政 治 大. ,. 立立. •‧. •‧ 國. ㈻㊫學. ,. y ,. Ch. engchi. 2025. er. al. 10%. n. 19.8%,. 65. io. , 2007. 2006. sit. Nat. ,. 2019. i n U. v. ,. , ‧ , ,. :. HCRC. , , ,. ,. , 53.
(63) ,. ,. 21. , ,. SWOT. ,. ,. HCRC. , ,. , ,. ,. 立立. ,. , 政 治 大. , , ,. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. Ch. engchi. 21. 54. i n U. v.
(64) 1. , 77 – 78 2. 2003, 1-10 3.. Baker, J.R. Iske, B.R, Drake,J. H; US Hemophilia Treatment Center population trends 1990–2010: patient diagnoses, demographics, health. ㈻㊫學. •‧ 國. 4.. 治 政 services utilization. Haemophilia (2013) 19, 21–26 大 立立 Tu TC, Liou WS, Chou TY, Lin TK, Lee CF, Chen JD, Cham TM, Chung MI. Prevalence, incidence, and factor concentrate usage trends of. 5.. •‧. hemophiliacs in Taiwan . Yonsei Med J. 2013 Jan 1;54(1):71-80. Porter, M.E, Competitive Strategy: Techniques for analysis industries and. y. Nat. .,. n. al. No. 003, 2009. er. io. 6. 7.. sit. competitor. New York: Free Pree, 1980. Ch. i n U. v. Liou WS, Tu TC, Cheng SN, Chou TY, Lee CF, Lin TK, Chung MI, Cham. engchi. TM. Secondary prophylaxis treatment versus on-demand treatment for patients with severe haemophilia A: comparisons of cost and outcomes in Taiwan. Haemophilia 2011: 17: 45-54. 8.. PL 9463: The Pulbic Health Service Act establishing the hemophilia diagnostic & treatment center program. No 1131 of Public Law 9463 Washington DC: Government Printing Office, 1975. 9.. Eme’rito-Carlos., Rodrignez-Mercha’m., Valentino, Leomard A., Current & Future issues in Hemophilia Care., Wiley-blackwell., 2011 55.
(65) 10.. (2012). ., Healthcare Industry Strategy Management. ., ISBN 978-986-194-234-6. 11.. (2010),. (Michael E. Porter),. .,. Competitive advantage : creating and sustaining superior performance. 12. Channom, D.K..SWOT analysis entry in handbook of strategic management. New York: M. Dekker. 1989 13. Franchini, M., Tagliaferri, A., Mannucio, P. The management of hemophilia in. elderly patients. Clin Interv Aging. 2007 September; 2(3): 361–368. 政 治 大 Implementation and Control 1967 立立. 14. Kolter, P., Keller, K., Marketing Management: Application, Planning,. 15. Keller, KL., Building Customer-Based brand equity: A blueprint for. •‧ 國. ㈻㊫學. creating strong brand. Marketing Science Institute. Report summary, 2001.. •‧. 01-107. n. er. io. sit. y. Nat. al. Ch. engchi. 56. i n U. v.
(66) 102. •‧. •‧ 國 io. sit. y. Nat. n. al. er. 3.. 5. ㈻㊫學. 2.. 2. 政: 治 大. 立立. 1.. 9. Ch. engchi. i n U. v. 325 87923311 : : 87923311 102. 16348 4. 10. 16. 30. 88012.
(67) 102. 立立. 政 治 大 9 2 5 2. •‧. •‧ 國. ㈻㊫學. n. er. io. sit. y. Nat. al. Ch. engchi. i n U. v. 325.
(68) 政 治 大. ㈻㊫學. •‧ 國. 立立 70. •‧. n. er. io. sit. y. Nat. al. Ch. engchi. i n U. v.
(69)
相關文件
吳佳勳 助研究員 國立台灣大學農經博士 葉長城 助研究員 國立政治大學政治學系博士 吳玉瑩 助研究員 國立台灣大學經濟博士 陳逸潔 分析師 國立台灣大學農經系博士生 林長慶
配合小學數學科課程的推行，與參與的學校 協作研究及發展 推動 STEM
We explicitly saw the dimensional reason for the occurrence of the magnetic catalysis on the basis of the scaling argument. However, the precise form of gap depends
Let T ⇤ be the temperature at which the GWs are produced from the cosmological phase transition. Without significant reheating, this temperature can be approximated by the
The growth in the number of vanco- mycin-induced thrombocytopenia cases presently seen may be associated with the increased use of the drug, especially in multiresistant patients
Animal or vegetable fats and oils and their fractiors, boiled, oxidised, dehydrated, sulphurised, blown, polymerised by heat in vacuum or in inert gas or otherwise chemically
Estimated resident population by age and sex in statistical local areas, New South Wales, June 1990 (No. Canberra, Australian Capital
First Taiwan Geometry Symposium, NCTS South () The Isoperimetric Problem in the Heisenberg group Hn November 20, 2010 13 / 44.. The Euclidean Isoperimetric Problem... The proof
